CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? Correale P, Pentimalli F, Nardone V, Giordano A, et al. Lancet Oncol 2022;23:e13.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Correale P, Pentimalli F, Nardone V, Giordano A, et al. CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? Lancet Oncol 2022;23:e13.
PMID: 34973223